Roche ‘walks away’ from ABPI

Roche has decided not to review its membership of the ABPI in a controversial move that has led analysts to question the effectiveness of...

J&J and Elan form Alzheimer’s agreement

Johnson & Johnson is to acquire the Elan Corporation’s Alzheimer's Immunotherapy Program (AIP Program), through a newly-formed company. As part of the...

HRA Pharma establishes UK presence

HRA Pharma has established a UK subsidiary, HRA Pharma UK Ltd, based in London. This is the company’s second subsidiary in Europe as...

First pediatric PAH therapy approved in EU

Actelion’s pediatric dispersible formulation of Tracleer (bosentan) for the treatment of pulmonary arterial hypertension (PAH) has been approved in the EU. The approval...

Pfizer triumphs at environmental awards

Pfizer has been recognised as a leader in environmental excellence at the recent Business Commitment to the Environment (BCE) awards. Twelve companies received recognition...

CORRECTION: MabThera recommended in Scotland

Scottish physicians are now able to prescribe MabThera (rituximab) on the NHS, following a positive recommendation by the Scottish Medicines Consortium (SMC). MabThera was...

GPs need swine flu guidance

A poll of GPs by has revealed that, so far, only 9% of GPs in the UK have been given regular, clear and concise...

Tamiflu discount for poorer countries

Roche is to provide its antiviral Tamiflu at a lower price to developing countries as part of a new initiative. Under the Tamiflu Reserves...

Viruses resistant to Tamiflu identified

Several cases of the H1N1 ‘swine flu’ virus have emerged that are resistant to antiviral drug Tamiflu (oseltaminvir). WHO has been informed by...

Novo Nordisk launches Victoza in UK

Novo Nordisk’s Victoza is now available for type 2 diabetes patients in the UK, following EU approval. Victoza is the first once-daily human Glucagon-like...

Latest articles

collaboration between LifeArc and The University of Kent to develop new pain medicines

Collaboration to develop potential new pain medicines

LifeArc® has signed a deal with The University of Kent to develop potential new pain medicines. They will collaborate on an ion channel drug discovery...
Dotmatics wins Queen's Award for Enterprise: International Trade

Dotmatics wins Queen’s Award for International Trade 2019

Provider of scientific informatics solutions and services, Dotmatics, has been recognised with a Queen’s Award for Enterprise: International Trade 2019. Dotmatics was founded in 2005...
The NHS in England carried out more than two million checks on people who feared they might have cancer last year

Record number of cancer checks carried out in England

The NHS in England carried out more than two million checks on people who feared they might have cancer last year. Patients underwent a record...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
Sobi is encouraging every person living with haemophilia to liberate their lives

Strategy to create ‘vision of life beyond haemophilia’ launches

To mark World Haemophilia Day, Sobi™ is launching Liberate Life, a vision of life beyond haemophilia. In a series of long-term commitments, Sobi seeks...

Market Access in practice: do you have a strategy?

This article is a little old... but if you're interested in Market Access we have plenty of new content: July 2018 Market Access Special Edition...

Understanding Multiple Sclerosis

Multiple sclerosis (MS) is a neurological condition affecting the central nervous system. ‘Sclerosis’ means the scarring or hardening of tiny patches of tissue; it...
Study by health experts shows that NHS productivity of the NHS has improved

NHS staff praised as productivity grows

A study by health experts has shown that the productivity of the NHS has improved almost two and a half times faster than the...